DongKook Pharmaceutical Co. Ltd (086450) — Working Capital to Net Assets Ratio
DongKook Pharmaceutical Co. Ltd (086450) has a Working Capital to Net Assets ratio of 37.6% as of March 2026. Working capital of ₩293.58 Billion (current assets of ₩571.73 Billion minus current liabilities of ₩278.14 Billion) is measured against net assets of ₩780.60 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See DongKook Pharmaceutical Co. Ltd (086450) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
DongKook Pharmaceutical Co. Ltd Working Capital to Net Assets (2014–2025)
This chart shows how DongKook Pharmaceutical Co. Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 37.6%, reflecting working capital of ₩293.58 Billion against net assets of ₩780.60 Billion KRW. For the complete balance sheet picture, see DongKook Pharmaceutical Co. Ltd asset portfolio.
Annual Working Capital to Net Assets for DongKook Pharmaceutical Co. Ltd (2014–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for DongKook Pharmaceutical Co. Ltd from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check DongKook Pharmaceutical Co. Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 39.0% | ₩297.98 Billion | ₩763.74 Billion | ₩565.40 Billion | ₩267.41 Billion | ▲ +4.1 pp |
| 2024 | 35.0% | ₩237.31 Billion | ₩678.98 Billion | ₩470.01 Billion | ₩232.69 Billion | ▲ +2.3 pp |
| 2023 | 32.6% | ₩188.04 Billion | ₩576.17 Billion | ₩419.20 Billion | ₩231.15 Billion | ▼ -4.6 pp |
| 2022 | 37.2% | ₩186.78 Billion | ₩501.94 Billion | ₩385.32 Billion | ₩198.54 Billion | ▼ -6.8 pp |
| 2021 | 44.0% | ₩199.96 Billion | ₩454.57 Billion | ₩420.23 Billion | ₩220.27 Billion | ▼ -17.7 pp |
| 2020 | 61.7% | ₩253.80 Billion | ₩411.37 Billion | ₩398.76 Billion | ₩144.97 Billion | ▼ -1.4 pp |
| 2019 | 63.1% | ₩229.01 Billion | ₩362.87 Billion | ₩339.02 Billion | ₩110.01 Billion | ▼ -3.4 pp |
| 2018 | 66.5% | ₩208.06 Billion | ₩313.02 Billion | ₩300.43 Billion | ₩92.37 Billion | ▼ -5.9 pp |
| 2017 | 72.4% | ₩191.00 Billion | ₩263.94 Billion | ₩271.19 Billion | ₩80.18 Billion | ▲ +4.5 pp |
| 2016 | 67.9% | ₩161.11 Billion | ₩237.32 Billion | ₩233.99 Billion | ₩72.89 Billion | ▼ -0.4 pp |
| 2015 | 68.3% | ₩136.35 Billion | ₩199.62 Billion | ₩195.18 Billion | ₩58.83 Billion | ▲ +0.1 pp |
| 2014 | 68.2% | ₩120.39 Billion | ₩176.57 Billion | ₩173.16 Billion | ₩52.77 Billion | — |